首页 | 本学科首页   官方微博 | 高级检索  
     

MELD评分评估血浆置换治疗慢性乙型重型肝炎的疗效
引用本文:刘雯. MELD评分评估血浆置换治疗慢性乙型重型肝炎的疗效[J]. 实用肝脏病杂志, 2011, 14(1): 29-30. DOI: 10.3969/j.issn.1672-5069.2011.01.010
作者姓名:刘雯
作者单位:第二人民医院肝病一科,安徽省阜阳市,236015
摘    要:目的应用终末期肝病模型(MELD)评价血浆置换(PE)治疗慢性乙型重型肝炎的临床疗效。方法对112例慢性乙型重型肝炎患者进行PE治疗,检测总胆红素、国际标准化比值和肌酐水平以计算MELD分值。按照治疗前患者MELD分值〈30分、30~40分和≥40分分成三组,观察各组3个月内的病死率。结果 PE治疗后112例患者血生化指标改善;3个月内,在MELD评分〈30的63例患者中,死亡12例(19%);在30≤MELD评分〈40分的34例患者中,死亡20例(58.8%);在MELD评分≥40分的15例患者中,死亡15例(100%,P〈0.05)。结论 MELD评分系统能预测PE治疗慢性乙型重型肝炎患者的预后。

关 键 词:慢性乙型肝炎  重型肝炎  血浆置换  终末期肝病模型

Model for end-stage liver disease to predict survival in patients with chronic severe hepatitis B
LIU Wen. Model for end-stage liver disease to predict survival in patients with chronic severe hepatitis B[J]. Journal of Clinical Hepatology, 2011, 14(1): 29-30. DOI: 10.3969/j.issn.1672-5069.2011.01.010
Authors:LIU Wen
Affiliation:LIU Wen.Department of Liver Disease,Second Municipal People's Hospital,Fuyang 236015,Anhui Province,China
Abstract:Objective To evaluate the value of model for end-stage liver disease(MELD)scoring system in predicting the prognosis of patients with chronic severe hepatitis B receiving plasma exchange.Methods Total serum bilirubin,international normalized ratio and creatinine were determined pre-treatment and post-treatment in 112 patients with chronic severe hepatitis B who were treated with plasma exchange.The patients were divided into three groups according to MELD score.The mortality rate within three months post-tr...
Keywords:Chronic hepatitis B  Severe hepatitis  Plasma exchange  Model for end-stage liver disease scoring system  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号